Latest filing published 25 May 2017 for Vyant Bio, Inc., €2,095.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Igor Gitelman: trading record in brief
All filings by Igor Gitelman on record concern Vyant Bio, Inc. Over a trading history stretching from 23 May 2017 to 25 May 2017, the count stands at 3 filings.
In open-market terms, that means 1 purchase worth €3,301 on one side and 1 sale worth €3,369 on the other. Sales outweigh purchases by €68. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise.
The newest entry dates from 25 May 2017: an option exercise of €2,095, in Vyant Bio, Inc. The last purchase on record was published on 25 May 2017, which is 3,455 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Igor Gitelman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 937 shares@ US$2.5023.9% of flowCommon Stock, par value $0.0001 per shareSEC:0001349929-17-000038:0
- 937 shares@ US$4.0238.4% of flowCommon Stock, par value $0.0001 per shareSEC:0001349929-17-000038:1
- 937 shares@ US$3.9537.7% of flowCommon Stock, par value $0.0001 per shareSEC:0001349929-17-000038:2Canonical exit: 23 Aug 2017 (T+90)
3 of 3 declarations
